Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel copper complex patent CN117069764A offers high thermal stability and fluorescence for optical manufacturing cost reduction and supply reliability.
Patent CN110002980A reveals Pd-catalyzed asymmetric naphthylation for high-ee chiral aldehydes. Offers supply chain stability and cost reduction in chiral catalyst manufacturing.
Novel metal-catalyzed synthesis offers mild conditions and high yields for phenyl pyrrolidine intermediates, ensuring supply chain stability and cost efficiency.
Novel palladium coordination polymer catalyst enables recyclable carbon-carbon coupling. Reduces contamination and supports scalable pharmaceutical intermediate manufacturing efficiently.
Novel palladium coordination polymer catalyst enables recyclable carbon-carbon coupling. Delivers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel 7-step route avoids resolution, offering cost-effective manufacturing of chiral proline derivatives for pharmaceutical intermediates.
Patent CN102850383A details a novel chiral zinc-nitrogen complex enabling efficient asymmetric catalysis for fine chemical manufacturing and supply chain optimization.
Patent CN113200921A reveals a room-temperature copper-catalyzed route for phenylbenzimidazoles, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel organocatalysts for asymmetric epoxidation offering high enantioselectivity without transition metals, ensuring reliable supply chain stability.
Catalyst-free synthesis method for high-purity pharmaceutical intermediates reducing cost and lead time for global supply chains.
Patent CN112010910B details a novel iridium-catalyzed synthesis of chiral ferrocene homoallylamines, offering high yields and enantioselectivity for cost-effective pharmaceutical intermediate manufacturing.
Patent CN1257468A reveals novel Cp*-metal catalysts for efficient asymmetric transfer hydrogenation, offering significant cost reduction in pharmaceutical manufacturing and safer processing.
Patent CN105294518B reveals high-yield arylsulfonyl synthesis. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN112047841B details a continuous esterification method for reduced coenzyme Q10 acetate, offering high purity, catalyst recycling, and superior stability for pharmaceutical supply chains.
Novel cuprous complex catalyst enables room temperature Buchwald-Hartwig coupling for high-purity pharmaceutical intermediates with reduced costs.
Discover advanced iridium-catalyzed synthesis for chiral bisallyl compounds with three consecutive chiral centers. Enhance supply chain reliability and reduce manufacturing costs.
Patent CN102010376A reveals a green aqueous synthesis for quinoxalines using biodegradable ionic liquids, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN108097323B discloses a green room-temperature synthesis of imines using ligand-modified gold catalysts, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN113234055B reveals a novel copper-polyselenide catalytic system for lactide synthesis, offering high optical purity and recyclable catalysts for cost-effective polylactic acid production.
Patent CN110511172A details loaded catalyst synthesis for bismaleimide. Ensures high purity and recyclable processes for reliable supply chain and cost efficiency.